Founded in 2014 by orthopedic surgeon Steven Goldberg, MD, Catalyst has set ourselves apart with an unwavering dedication to make shoulder replacements less invasive, with fewer complications and a more natural-feeling shoulder after surgery. Whether through total shoulder replacements, reverse shoulder arthroplasty, or other innovative procedures, we strive to advance techniques and devices for orthopedic surgery to maximize outcomes for patients, surgeons and the broader healthcare system.
PURPOSEFULLY DESIGNED™
We’re advancing the world of shoulder arthroplasty.
Experience what sets us apart.
DR. STEVEN GOLDBERG
OUR VISION
To be the best pure play shoulder company that sets new standards in shoulder surgery.
OUR MISSION
To design innovative products and solutions that continually improve shoulder replacement outcomes.
- Products based on years of proven research and clinical experience
- Precise and consistent implant placement
- Streamlined surgical techniques
- Maximal preservation of healthy tissues
- New standards in efficiencies for all parties involved
OUR QUALITY POLICY
Our pledge at Catalyst OrthoScience is to deliver the highest quality medical devices that will meet or exceed the expectations of our customers, meet regulatory requirements and demonstrate our commitment to excellence.
As part of this commitment, Catalyst OrthoScience will strive to continually improve the safety and efficacy of our products through an effective quality management system.
JOIN THE TEAM
If you’re ready to help us lead the evolution of shoulder arthroplasty, we’re ready for you.
SEE OPEN POSITIONS
NEWS
Catalyst OrthoScience Receives FDA 510(k) Clearance for Expanded Indications of the Fracture Shoulder System
New indications expand applications for Catalyst Fracture System to anatomic shoulder restorations NAPLES, Fla., Dec. 3, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that its Catalyst Fracture Shoulder System has received FDA 510(k) clearance for additional indications that now include…
Read More
CATALYST ORTHOSCIENCE Secures $15.0 Million in Growth Financing
RC Capital, Mutual Capital Partners and Western Alliance Bank, reinforce long-term confidence in Catalyst’s vision and leadership; Dr. Theodore Blaine joins Catalyst board of directors NAPLES, Fla., Oct. 22, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced the…
Read More
CATALYST ORTHOSCIENCE Announces Full Commercial Release of Fracture Shoulder System
The new system designed to improve reverse shoulder arthroplasty for proximal humeral fractures includes patented technology that helps reduce surgical complexity and drive clinical confidence NAPLES, Fla., August 12, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the…
Read More
1000-0002-A